News for Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK)

PR NewswireHONG KONG, May 15, 2025 HONG KONG, May 15, 2025 /PRNewswire/ -- On May 15, 2025, the latest announcement released by the National Medical Produc

Rising benefits of autologous fat transfer over derma fillers, rising accidents, rising safety margin offered by the treatment, and increasing number of...

/PRNewswire/ -- The dermatology devices market size is estimated to increase by USD 124,693.13 million from 2022 to 2027, at a CAGR of 8.42%, according to a...

Empowering Women's Health: Menstrual Cramps Treatment Market Explores Innovative Solutions to Alleviate Pain and Discomfort, Anticipated to Witness...

The Rhinoplasty market, valued at US$ 4,488.5 million in 2023, is set to experience a CAGR of 7.9% during the forecast period from 2023 to 2030, as it...

/PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd together with its subsidiaries, is pleased to announce that Xuanzhu Biopharmaceutical Co., Ltd....

Accelerating the Layout of Diabetes and ComplicationsHONG KONG, Jan. 4, 2023 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Co., Ltd. (the '...

Eli Lilly and Co has the highest number of type 2 diabetes drugs in development...

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its... | March 28, 2021